Foundayo (orforglipron) is Eli Lilly's once-daily weight-management tablet, approved on 1 April 2026. Its price is set by Lilly's published terms, which carry a regular ladder, two temporary reductions, a refill offer on the top doses and a savings card with caps that are tighter than they look. This page reads all of them from foundayo.lilly.com on 2 October 2026 and works out what a year costs.
How Foundayo compares with the other weight-loss tablet, trial for trial, is on Foundayo vs Wegovy pill; both pills' ladders side by side are on GLP-1 pills cost.
Self-pay prices by strength
Every price is for a 30-day bottle of 30 tablets.
| Strength | Regular price | Price through 31 Dec 2026 | With the refill offer |
|---|---|---|---|
| 0.8 mg | $149 | $149 | — |
| 2.5 mg | $199 | $149 (temporary) | — |
| 5.5 mg | $299 | $199 (temporary) | — |
| 9 mg | $299 | $299 | — |
| 14.5 mg | $349 | $349 | $299 |
| 17.2 mg | $349 | $349 | $299 |
The refill offer. Lilly applies the $299 price automatically on the first purchase of 14.5 mg or 17.2 mg. "To continue to be eligible … you must complete your refill purchase … within 45 days of the delivery/received date of your previous Foundayo prescription fill." Miss the window and the price returns to $349. A 30-day bottle leaves 15 days of slack before the window closes.
If the discount is not applied at the pharmacy. The terms allow a post-transaction reimbursement claim when Lilly "was not able to verify such at the point of sale", through an online portal or by post, with the original receipt — postmarked no later than 31 March 2027.
Lilly offers these prices through LillyDirect and through "other pharmacy"; the partner pharmacies behind Lilly's direct-to-patient channel are listed separately. Lilly's page also marks the self-pay price as HSA/FSA eligible, subject to the plan's administrator.
A year of Foundayo, in dollars
Monthly prices hide the fact that a "month" here is 30 days, and that nobody stays on one strength forever. At a single strength for a full year:
| Strength and price | Bottles in 365 days | Cost for the year |
|---|---|---|
| 17.2 mg at $299 (refill offer kept) | 12.17 | ≈ $3,638 |
| 17.2 mg at $349 (regular) | 12.17 | ≈ $4,247 |
| 9 mg at $299 | 12.17 | ≈ $3,638 |
| 5.5 mg at $199 (temporary price, if extended) | 12.17 | ≈ $2,421 |
glp1ledger arithmetic: 365 ÷ 30 = 12.17 bottles.
The $299 top-dose price puts Foundayo level with the Wegovy pill's $299 price at 9 and 25 mg — the same $3,638 for a year — read in full on Wegovy pill cost. The label's dose steps are at least 30 days each, so a first year includes lower-priced months; the exact total depends on how long a person stays at each strength, which is the prescriber's decision.
The savings card when insurance covers Foundayo
| Term | What Lilly's card says |
|---|---|
| Patient pays | "As little as $25" for a 1-, 2- or 3-month fill (30, 60 or 90 days) |
| Monthly cap | $100 per 1-month fill · $200 per 2-month · $300 per 3-month |
| Yearly cap | $1,000 per calendar year |
| Fill limit | 10 fills per calendar year |
| Expires | 12/31/2026 |
The patient pays $25 when the plan's copay for a 30-day fill is $125 or less, and the copay minus $100 above that. The yearly cap is exactly ten monthly caps: 10 × $100 = $1,000.
The ten-fill limit is the binding term. At one bottle per fill, ten fills cover 300 days, leaving 65 days of the year outside the card. Lilly's Zepbound and Mounjaro cards allow 13 fills; Foundayo's allows 10 (compare the Zepbound card's 13-fill terms and Mounjaro savings card). Because a 2- or 3-month fill counts as a single fill, longer fills stretch the limit — but the $1,000 cap still applies, and a plan may not allow a 90-day fill.
The savings card when insurance does not cover Foundayo
For people with commercial insurance that excludes Foundayo, the card sets a price by strength and a maximum monthly saving. Add the two and every strength comes to the same number:
| Strength | Card price | Maximum monthly saving | Price + saving |
|---|---|---|---|
| 0.8 mg | $149 | $520 | $669 |
| 2.5 mg | $149 | $520 | $669 |
| 5.5 mg | $199 | $470 | $669 |
| 9 · 14.5 · 17.2 mg | $299 | $370 | $669 |
glp1ledger arithmetic from Lilly's terms. A cap is a ceiling, not necessarily the pharmacy price, so $669 is the reference price the card is built around rather than a price Lilly publishes.
So the card discounts from a flat $669 for a 30-day bottle at every strength, the way Lilly's Mounjaro card terms imply $1,146 for a 28-day pen fill (Mounjaro cost). This tier is also limited to 10 fills a year, and its top-dose $299 is subject to the same 45-day refill condition.
Who is excluded
Both card tiers require a prescription "for an approved use consistent with FDA approved product labeling" — Foundayo's label is for chronic weight management in adults with obesity, or overweight with a weight-related condition — commercial drug insurance, age 18 or over and US or Puerto Rico residence. They exclude anyone enrolled in "Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state prescription drug assistance program". As with Lilly's other cards, plans running an alternate funding programme make their members ineligible, and the card cannot be combined with any other discount.
Medicare
Lilly's page lists Foundayo at $50 a month through the Medicare GLP-1 Bridge "for eligible Medicare Part D patients with Foundayo prescription for weight management", with eligibility "based on Medicare GLP-1 Bridge Clinical Criteria" and "not a guarantee of coverage". How that programme works is on the Medicare GLP-1 Bridge.
What the terms do not say
- Anything about 2027. The card and both temporary reductions end on 31 December 2026.
- Whether a plan covers Foundayo. That depends on the plan's formulary; see GLP-1 insurance coverage.
- Whether the refill offer survives a dose change. The terms tie it to buying "your refill" of the 14.5 or 17.2 mg dose within 45 days and say nothing about moving between those two strengths.
This page reports Lilly's published prices and terms. It is not advice on which medicine or which price route to use; treatment decisions belong with the prescriber. All GLP-1 prices across brands are on GLP-1 cost.
Sources
- Eli Lilly and Company, "Foundayo™ (orforglipron) Coverage & Savings: Self-Pay & Savings Card" — price cards, Full Terms and Conditions for the Foundayo Savings Card Program, Purchase Offer Terms and Conditions, Post-Transaction Reimbursement and the Medicare GLP-1 Bridge card, foundayo.lilly.com/coverage-savings, read 2 October 2026.
- Foundayo prescribing information (Eli Lilly and Company), DailyMed set ID 8ac446c5-feba-474f-a103-23facb9b5c62, effective 2026-07-29 — Indications and Usage, Dosage and Administration (at least 30 days per dose step), How Supplied (bottles of 30 tablets).
- Novo Nordisk, NovoCare Pharmacy terms (Wegovy tablet self-pay prices), novocare.com/eligibility/pharmacy.html, read 2 October 2026 (comparison only).